Home

Avista Acquisition, LLC

CIK 1686388 · last filed 2020-03-16

Avista Acquisition, LLC is a corporate insider who has filed 5 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing shows the insider bought $17.3M of ORGO on Mar 16, 2020. Across all open-market trades the lifetime net is +$61.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $43.6M across reported positions. The firm reports its address in New York, NY. 16 SEC filings were submitted jointly with Avista Acquisition Corp.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$43.63M

Companies

2

Total Filings

5

Lifetime Open-Market Net

$61.93M

Filer Profile

Reported Address
65 EAST 55TH STREET
18TH FLOOR
NEW YORK, NY 10022
Phone
(212) 593-6900
State of Incorporation
DE
Related Filers
Avista Acquisition Corp. — 16 joint filings, latest 2021-05-18
David F Burgstahler — 15 joint filings, latest 2021-05-18
Thompson Dean — 15 joint filings, latest 2021-05-18
Avista Capital Partners IV GP, L.P. — 9 joint filings, latest 2021-05-18
Avista Capital Partners IV, L.P. — 9 joint filings, latest 2021-05-18
ACP HIP Splitter (Offshore), LP — same reported address
Avista Capital Partners (Offshore) II-A, LP — same reported address
Avista Capital Partners GP, LLC — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ORGO Director 25,517,514 $1.71 $43.63M $61.93M 3 2020-03-16
Organogenesis Holdings Inc. (AHPAW) Delisted 10%+ Owner — $0.69 — $0 2 2018-12-12

Recent Filings

5 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-03-16 ORGO Buy (P) +4,338,792 $17.29M EDGAR
2019-09-10 ORGO Buy (P) +4,296,000 $22.26M EDGAR
2019-09-05 ORGO Buy (P) +4,620,800 $22.38M EDGAR
2018-12-12 Organogenesis Holdings Inc. (AHPAW) Delisted Other (J) — $0 EDGAR
2018-11-01 Organogenesis Holdings Inc. (AHPAW) Delisted Other (J) — $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.